Global Circulating Tumor Cell Market Size, Status and Forecast 2020-2026

    • ID: AR2947502
    • 30 July, 2020
    • Other
    • Region: Global
    • 130 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Circulating Tumor Cell Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Circulating Tumor Cell Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 CTC Enrichment
      • 1.4.3 CTC Detection
      • 1.4.4 CTC Analysis
    • 1.5 Market by Application
      • 1.5.1 Global Circulating Tumor Cell Market Share by Application: 2020 VS 2026
      • 1.5.2 Breast Cancer
      • 1.5.3 Prostate Cancer
      • 1.5.4 Colorectal Cancer
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Global Circulating Tumor Cell Market Perspective (2015-2026)
    • 2.2 Global Circulating Tumor Cell Growth Trends by Regions
      • 2.2.1 Circulating Tumor Cell Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Circulating Tumor Cell Historic Market Share by Regions (2015-2020)
      • 2.2.3 Circulating Tumor Cell Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Circulating Tumor Cell Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Circulating Tumor Cell Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Circulating Tumor Cell Players by Market Size
      • 3.1.1 Global Top Circulating Tumor Cell Players by Revenue (2015-2020)
      • 3.1.2 Global Circulating Tumor Cell Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Circulating Tumor Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Circulating Tumor Cell Market Concentration Ratio
      • 3.2.1 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Revenue in 2019
    • 3.3 Circulating Tumor Cell Key Players Head office and Area Served
    • 3.4 Key Players Circulating Tumor Cell Product Solution and Service
    • 3.5 Date of Enter into Circulating Tumor Cell Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Circulating Tumor Cell Historic Market Size by Type (2015-2020)
    • 4.2 Global Circulating Tumor Cell Forecasted Market Size by Type (2021-2026)

    5 Market Size by Application (2015-2026)

    • 5.1 Global Circulating Tumor Cell Market Size by Application (2015-2020)
    • 5.2 Global Circulating Tumor Cell Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Circulating Tumor Cell Market Size (2015-2020)
    • 6.2 Circulating Tumor Cell Key Players in North America (2019-2020)
    • 6.3 North America Circulating Tumor Cell Market Size by Type (2015-2020)
    • 6.4 North America Circulating Tumor Cell Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Circulating Tumor Cell Market Size (2015-2020)
    • 7.2 Circulating Tumor Cell Key Players in Europe (2019-2020)
    • 7.3 Europe Circulating Tumor Cell Market Size by Type (2015-2020)
    • 7.4 Europe Circulating Tumor Cell Market Size by Application (2015-2020)

    8 China

    • 8.1 China Circulating Tumor Cell Market Size (2015-2020)
    • 8.2 Circulating Tumor Cell Key Players in China (2019-2020)
    • 8.3 China Circulating Tumor Cell Market Size by Type (2015-2020)
    • 8.4 China Circulating Tumor Cell Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Circulating Tumor Cell Market Size (2015-2020)
    • 9.2 Circulating Tumor Cell Key Players in Japan (2019-2020)
    • 9.3 Japan Circulating Tumor Cell Market Size by Type (2015-2020)
    • 9.4 Japan Circulating Tumor Cell Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Circulating Tumor Cell Market Size (2015-2020)
    • 10.2 Circulating Tumor Cell Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Circulating Tumor Cell Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Circulating Tumor Cell Market Size by Application (2015-2020)

    11 India

    • 11.1 India Circulating Tumor Cell Market Size (2015-2020)
    • 11.2 Circulating Tumor Cell Key Players in India (2019-2020)
    • 11.3 India Circulating Tumor Cell Market Size by Type (2015-2020)
    • 11.4 India Circulating Tumor Cell Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Circulating Tumor Cell Market Size (2015-2020)
    • 12.2 Circulating Tumor Cell Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Circulating Tumor Cell Market Size by Type (2015-2020)
    • 12.4 Central & South America Circulating Tumor Cell Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Menarini-Silicon Biosystems
      • 13.1.1 Menarini-Silicon Biosystems Company Details
      • 13.1.2 Menarini-Silicon Biosystems Business Overview
      • 13.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Introduction
      • 13.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2015-2020))
      • 13.1.5 Menarini-Silicon Biosystems Recent Development
    • 13.2 Qiagen(Adnagen)
      • 13.2.1 Qiagen(Adnagen) Company Details
      • 13.2.2 Qiagen(Adnagen) Business Overview
      • 13.2.3 Qiagen(Adnagen) Circulating Tumor Cell Introduction
      • 13.2.4 Qiagen(Adnagen) Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.2.5 Qiagen(Adnagen) Recent Development
    • 13.3 Clearbridge Biomedics
      • 13.3.1 Clearbridge Biomedics Company Details
      • 13.3.2 Clearbridge Biomedics Business Overview
      • 13.3.3 Clearbridge Biomedics Circulating Tumor Cell Introduction
      • 13.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.3.5 Clearbridge Biomedics Recent Development
    • 13.4 Celsee
      • 13.4.1 Celsee Company Details
      • 13.4.2 Celsee Business Overview
      • 13.4.3 Celsee Circulating Tumor Cell Introduction
      • 13.4.4 Celsee Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.4.5 Celsee Recent Development
    • 13.5 Fluidigm
      • 13.5.1 Fluidigm Company Details
      • 13.5.2 Fluidigm Business Overview
      • 13.5.3 Fluidigm Circulating Tumor Cell Introduction
      • 13.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.5.5 Fluidigm Recent Development
    • 13.6 ApoCell
      • 13.6.1 ApoCell Company Details
      • 13.6.2 ApoCell Business Overview
      • 13.6.3 ApoCell Circulating Tumor Cell Introduction
      • 13.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.6.5 ApoCell Recent Development
    • 13.7 Greiner Bio-one GmbH
      • 13.7.1 Greiner Bio-one GmbH Company Details
      • 13.7.2 Greiner Bio-one GmbH Business Overview
      • 13.7.3 Greiner Bio-one GmbH Circulating Tumor Cell Introduction
      • 13.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.7.5 Greiner Bio-one GmbH Recent Development
    • 13.8 Advanced Cell Diagnostics
      • 13.8.1 Advanced Cell Diagnostics Company Details
      • 13.8.2 Advanced Cell Diagnostics Business Overview
      • 13.8.3 Advanced Cell Diagnostics Circulating Tumor Cell Introduction
      • 13.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.8.5 Advanced Cell Diagnostics Recent Development
    • 13.9 Aviva Biosciences
      • 13.9.1 Aviva Biosciences Company Details
      • 13.9.2 Aviva Biosciences Business Overview
      • 13.9.3 Aviva Biosciences Circulating Tumor Cell Introduction
      • 13.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.9.5 Aviva Biosciences Recent Development
    • 13.10 Fluxion Biosciences
      • 13.10.1 Fluxion Biosciences Company Details
      • 13.10.2 Fluxion Biosciences Business Overview
      • 13.10.3 Fluxion Biosciences Circulating Tumor Cell Introduction
      • 13.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2015-2020)
      • 13.10.5 Fluxion Biosciences Recent Development
    • 13.11 Sysmex Corporation
      • 10.11.1 Sysmex Corporation Company Details
      • 10.11.2 Sysmex Corporation Business Overview
      • 10.11.3 Sysmex Corporation Circulating Tumor Cell Introduction
      • 10.11.4 Sysmex Corporation Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.11.5 Sysmex Corporation Recent Development
    • 13.12 Epic Sciences
      • 10.12.1 Epic Sciences Company Details
      • 10.12.2 Epic Sciences Business Overview
      • 10.12.3 Epic Sciences Circulating Tumor Cell Introduction
      • 10.12.4 Epic Sciences Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.12.5 Epic Sciences Recent Development
    • 13.13 Cynvenio
      • 10.13.1 Cynvenio Company Details
      • 10.13.2 Cynvenio Business Overview
      • 10.13.3 Cynvenio Circulating Tumor Cell Introduction
      • 10.13.4 Cynvenio Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.13.5 Cynvenio Recent Development
    • 13.14 CytoTrack
      • 10.14.1 CytoTrack Company Details
      • 10.14.2 CytoTrack Business Overview
      • 10.14.3 CytoTrack Circulating Tumor Cell Introduction
      • 10.14.4 CytoTrack Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.14.5 CytoTrack Recent Development
    • 13.15 Ikonisys
      • 10.15.1 Ikonisys Company Details
      • 10.15.2 Ikonisys Business Overview
      • 10.15.3 Ikonisys Circulating Tumor Cell Introduction
      • 10.15.4 Ikonisys Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.15.5 Ikonisys Recent Development
    • 13.16 Vortex BioSciences
      • 10.16.1 Vortex BioSciences Company Details
      • 10.16.2 Vortex BioSciences Business Overview
      • 10.16.3 Vortex BioSciences Circulating Tumor Cell Introduction
      • 10.16.4 Vortex BioSciences Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.16.5 Vortex BioSciences Recent Development
    • 13.17 Gilupi
      • 10.17.1 Gilupi Company Details
      • 10.17.2 Gilupi Business Overview
      • 10.17.3 Gilupi Circulating Tumor Cell Introduction
      • 10.17.4 Gilupi Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.17.5 Gilupi Recent Development
    • 13.18 Biocept
      • 10.18.1 Biocept Company Details
      • 10.18.2 Biocept Business Overview
      • 10.18.3 Biocept Circulating Tumor Cell Introduction
      • 10.18.4 Biocept Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.18.5 Biocept Recent Development
    • 13.19 ScreenCell
      • 10.19.1 ScreenCell Company Details
      • 10.19.2 ScreenCell Business Overview
      • 10.19.3 ScreenCell Circulating Tumor Cell Introduction
      • 10.19.4 ScreenCell Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.19.5 ScreenCell Recent Development
    • 13.20 ANGLE
      • 10.20.1 ANGLE Company Details
      • 10.20.2 ANGLE Business Overview
      • 10.20.3 ANGLE Circulating Tumor Cell Introduction
      • 10.20.4 ANGLE Revenue in Circulating Tumor Cell Business (2015-2020)
      • 10.20.5 ANGLE Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Circulating Tumor Cell market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      The key players covered in this study
      Menarini-Silicon Biosystems
      Qiagen(Adnagen)
      Clearbridge Biomedics
      Celsee
      Fluidigm
      ApoCell
      Greiner Bio-one GmbH
      Advanced Cell Diagnostics
      Aviva Biosciences
      Fluxion Biosciences
      Sysmex Corporation
      Epic Sciences
      Cynvenio
      CytoTrack
      Ikonisys
      Vortex BioSciences
      Gilupi
      Biocept
      ScreenCell
      ANGLE

      Market segment by Type, the product can be split into
      CTC Enrichment
      CTC Detection
      CTC Analysis
      Market segment by Application, split into
      Breast Cancer
      Prostate Cancer
      Colorectal Cancer
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America



      Summary:
      Circulating Tumor Cell Market Research Report is about Circulating Tumor Cell Industry study. Get complete Circulating Tumor Cell market research report published after Market Study, Industrial Analysis with Trends & Statistics. Circulating Tumor Cell Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED